Catalyst
Slingshot members are tracking this event:
FDA Priority Review date for Venetoclax Set mid-2016
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
ABBV |
|
|
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 11, 2016
Occurred Source:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm495253.htm
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Venetoclax, Chronic Lymphocytic Leukemia, Bcl-2 Inhibitor, 17p Deletion, B-cell Lymphoma-2